Diisopropylethylamine → HCID 25226444, compound
Reaction equation
[CH3:1][C:2]1[CH:3]=[C:4]([C:8]2[CH:9]=[N:10][C:11]([N:17]3[CH:21]=[CH:20][C:19]([CH3:22])=[N:18]3)=[C:12]([C:14]([OH:16])=O)[CH:13]=2)[CH:5]=[N:6][CH:7]=1.[CH3:23][N:24]1[C:33]2[C:28](=[CH:29][C:30]([CH2:34][NH2:35])=[CH:31][CH:32]=2)[CH2:27][CH2:26][CH2:25]1.CCCP(O)(O)=O.CCN(C(C)C)C(C)C>C(#N)C>[CH3:1][C:2]1[CH:3]=[C:4]([C:8]2[CH:9]=[N:10][C:11]([N:17]3[CH:21]=[CH:20][C:19]([CH3:22])=[N:18]3)=[C:12]([C:14]([NH:35][CH2:34][C:30]3[CH:29]=[C:28]4[C:33](=[CH:32][CH:31]=3)[N:24]([CH3:23])[CH2:25][CH2:26][CH2:27]4)=[O:16])[CH:13]=2)[CH:5]=[N:6][CH:7]=1Participants
Conditions
- Temperature
- 40 °C
Procedure
To a solution of 5′-methyl-6-(3-methyl-1H-pyrazol-1-yl)-3,3′-bipyridine-5-carboxylic acid (5-2, 0.025 g, 0.085 mmol) and 1-(1-methyl-1,2,3,4-tetrahydroquinolin-6-yl)methanamine (0.015 g, 0.085 mmol) in ACN (0.85 mL) was added 1-propylphosphonic acid cyclic anhydride (T3P, 0.15 mL, 0.255 mmol) followed by Hunig's base (0.089 mL, 0.51 mmol) and the system was stirred at 40° C. for 1 h in an oil bath. The reaction mixture was cooled and partitioned between EtOAc and water, washed with saturated sodium bicarbonate and dried over magnesium sulfate. The reaction mixture was filtered, concentrated and purified via normal phase chromatography (0→10% MeOH in EtOAc) to afford the title compound (5-3) as a bone powder. 1H NMR (500 MHz, CDCl3) δ 8.68 (m, 1H), 8.51 (m, 1H), 8.29 (m, 1H), 8.22 (m, 1H), 7.72 (m, 1H), 7.12 (m, 1H), 7.0 (m, 1H), 6.90 (m, 1H), 6.54 (m, 1H), 6.27 (m, 1H), 4.46 (m, 2H), 3.22(m, 2H), 2.88 (s, 3H), 2.74 (m, 2H), 2.44 (s, 3H), 2.28 (s, 3H), 1.97 (m, 2H). HRMS [M+H] C27H28N6O calc'd 453.2391, found 453.2397.
Workup
- temperatureThe reaction mixture was cooled
- custompartitioned between EtOAc and water
- washwashed with saturated sodium bicarbonate
- dry with materialdried over magnesium sulfate
- filtrationThe reaction mixture was filtered
- concentrationconcentrated
- custompurified via normal phase chromatography (0→10% MeOH in EtOAc)
Sources & evidence
- ORD record
- ord-6d08999fe95d4d08b890d76d14e8e4d4
- Source dataset
- uspto-grants-2011_08
- Patent number
- US08003797B2
Reaction notes
Loading…